Key Takeaways
- • North American insurers reduced median private equity allocations to 2.3% in 2025 from 2.8% in 2024, while European insurers cut allocations more steeply to 1.8% from 2.9%—marking the first year-over-year decline in five years for either region.
- • The pullback reflects a rotation rather than a full retreat from alternatives; capital has shifted at scale into private credit, with Blackstone's credit and insurance segment expanding 18% to $375.5 billion in 2024 and reaching $432.3 billion by Q3 2025.
- • Private equity's exit challenge drives institutional demand reduction, with 80% of surveyed investors citing exits as a top concern for the next 12 months, constraining capital return velocity and portfolio liquidity management.
- • European insurers face compounding regulatory headwinds under Solvency II, where non-qualifying private equity investments carry a 49% capital charge plus symmetric adjustment, historically constraining European life insurer allocations to approximately 2% and non-life insurers to around 1%.
- • Potential regulatory relief on the horizon may reverse the pullback trend, suggesting the current allocation reduction could be cyclical rather than structural.
Summary
However, this pullback should be characterized as a strategic rotation within the alternatives ecosystem rather than a wholesale retreat from alternative investments. Capital released from private equity has flowed substantially into private credit strategies, which offer more favorable liquidity profiles and return timing characteristics. Blackstone's credit and insurance segment illustrates this migration at institutional scale: the division expanded 18% to $375.5 billion in 2024 and reached $432.3 billion by the third quarter of 2025, demonstrating sustained demand for credit-focused alternatives despite private equity headwinds.
The primary drivers of the private equity pullback are distinct but mutually reinforcing. First, private equity's persistent exit challenge has materially slowed capital repatriation, creating friction for insurers managing liquidity profiles and capital allocation cycles. According to Preqin's 2025 Global Reports, 80% of surveyed investors identified exits as a critical concern for the coming 12 months, underscoring the severity of this constraint. Second, regulatory burden—particularly acute in Europe under Solvency II—creates structural disincentives for expanded private equity allocations. Under the Solvency II standard formula, private equity investments lacking preferential treatment face a 49% capital charge plus symmetric adjustment, historically keeping European life insurers' allocations near 2% and non-life insurers near 1% of portfolios.
The outlook suggests potential near-term relief. Regulatory momentum toward Solvency II reform may ease capital requirements for private equity, potentially reversing the current allocation trend. This structural regulatory evolution could catalyze a rebalancing toward private equity once exit conditions stabilize and capital return visibility improves. For institutional investors, the dynamic underscores the importance of distinguishing between cyclical headwinds and secular shifts in insurer risk appetite for illiquid alternatives.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.